Angiogenic biomarkers in pregnancy: defining maternal and fetal health

Keyphrases

• Cardiovascular Disease 100%
• Diabetes 100%
• Preeclampsia 100%
• Maternal Health 100%
• Fetal Health 100%
• Angiogenic Biomarkers 100%
• Placental Growth Factor (PlGF) 66%
• Growth Factor Concentration 66%
• Angiogenic Proteins 66%
• Future Cardiovascular Disease 66%
• Soluble Endoglin 66%
• Cardiovascular Events 33%
• Risk Factors 33%
• Decreased Risk 33%
• Clinical Characteristics 33%
• Breast Cancer 33%
• Breast Cancer Risk 33%
• Vascular Endothelial Growth Factor 33%
• Hemoglobin A1c (HbA1c) 33%
• Predictive Value 33%
• Fasting Plasma Glucose 33%
• Elderly Patients 33%
• Specific Pattern 33%
• Disease Targets 33%
• Dysregulation 33%
• Preeclamptic 33%
• Predictive Marker 33%
• Predictive Role 33%
• Maternal Characteristics 33%
• Soluble Fms-like Tyrosine kinase-1 (sFlt-1) 33%
• Diabetic Vascular Complications 33%
• Diagnostic Role 33%
• Prophylactic Program 33%

Medicine and Dentistry

• Biological Marker 100%
• Cardiovascular Disease 100%
• Diabetes 60%
• Pre-Eclampsia 60%
• Breast Cancer 40%
• Angiogenic Protein 40%
• Placental Growth Factor 40%
• Endoglin 40%
• Cardiovascular System 20%
• Diagnosis 20%
• Hemoglobin A1c 20%
• Elderly Patient 20%
• Vasculotropin 20%
• Protein Tyrosine Kinase 20%

Biochemistry, Genetics and Molecular Biology

• Placental Growth Factor 100%
• Endoglin 100%
• Vascular Endothelial Growth Factor 50%
• Soluble Fms-Like Tyrosine Kinase-1 50%